Baxter International Inc. (BAX) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Baxter International is combating plastic pollution by implementing eco-materials, which contrasts with the active deployment of software robots for home dialysis. The EV/EBITDA valuation multiple for heavy business helps align these costs with efficiency, while the value of 12.09 reflects the metric's balance. Stability is provided by the global reach of equipment supplies for intensive care and surgery, shielding the company from local risks.
Comprehensive metric breakdowns and analytics for baxter.com (BAX)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- company total debt and liquidity indicators:
- business earnings and investment ratios data:
BAX - Company Profit|Future Profit Baxter International|BAX - Market Price to Net Income Ratio|Future Price to Earnings Baxter International|BAX - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Baxter Healthcare|BAX - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Baxter|BAX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months baxter.com|BAX - Earnings per share growth this year|Expected earnings per share growth for next year Baxter International
Fundamental company analysis:BAX (Baxter Corp)
The EV/EBITDA multiple determines the value of a business relative to its operating profit before depreciation and interest. Investors utilize this indicator to analyze a company's resilience to debt loads and tax pressure. The current EV/EBITDA valuation helps identify a market bottom or a structural crisis in a timely manner. This is critical for Baxter International (BAX), as geopolitical risks in Asia could slow expansion and reduce asset efficiency.
Competitors of Baxter International (BAX)
EV/EBITDA Multiple ISRG (Intuitive Surgical Inc)|Total Company Value to Operating Income Before Depreciation Ratio Danaher Corporation Inc. (DHR)|BDX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|STE (steris.com) - Enterprise Value to Operating Income Before Depreciation|West Pharmaceutical Services, Inc. (WST) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|MASI - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio STVN|TFX (Teleflex Corp) - Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Merit Medical Systems (MMSI)|NVST (envistaco.com) - Business Value to Operating Income Before Depreciation|ICU Medical - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Dentsply Sirona Inc XRAY|LMAT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|AtriCure Medical (ATRC) - Enterprise Value to EBITDA Ratio|STAA: EV/EBITDA Multiple|Company Value to EBITDA ChromaDex (NAGE)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ZimVie|Enterprise Value to Operating Income Before Depreciation ANGO (AngioDynamics Inc)|Enterprise Value to EBITDA Ratio CERS (Cerus Corp)|Enterprise Value to Operating Income Before Depreciation Ratio TKNO|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Monogram Technologies MGRM|Total Company Value to Operating Income Before Depreciation Ratio Sharps Technology Inc (STSS)|InfuSystem Inc - EV/EBITDA Multiple|UTMD: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|KRMD: EV/EBITDA Multiple|Nyxoah S.A (NYXH) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio MBOT|Enterprise Value to Operating Income Before Depreciation PDEX (pro-dex.com)|Enterprise Value to EBITDA Ratio ZTEK (Zentek)|Enterprise Value to Operating Income Before Depreciation Ratio ELUT|EV/EBITDA Multiple MLSS (Milestone Scientific Corp)|NEXGEL Inc (NXGL) - Company Value to EBITDA|RVP - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation HBIO (Harvard Bioscience Inc.)|FEMY (Femasys) - Enterprise Value to EBITDA Ratio|Meihua Medical Technologies Co., Ltd. - Business Value to Operating Income Before Depreciation|POAI (Predictive Oncology Inc) - EV/EBITDA Multiple|Callan JMB Corp (CJMB) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Atrion Corporation (ATRI)|neurometrix.com - Enterprise Value to Operating Income Before Depreciation
